Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 38

1.

Surgical treatment for isolated mitral valve endocarditis: a 16-year single-centre experience.

Perrotta S, Fröjd V, Lepore V, Schersten H, Jeppsson A, Svensson G.

Eur J Cardiothorac Surg. 2018 Mar 1;53(3):576-581. doi: 10.1093/ejcts/ezx416.

PMID:
29186533
2.

Long-Term Risk of Ischemic Stroke After the Cox-Maze III Procedure for Atrial Fibrillation.

Albåge A, Sartipy U, Kennebäck G, Johansson B, Scherstén H, Jidéus L; Swedish Arrhythmia Surgery Group.

Ann Thorac Surg. 2017 Aug;104(2):523-529. doi: 10.1016/j.athoracsur.2016.11.065. Epub 2017 Feb 24.

PMID:
28242081
3.

Continuous improvement in outcome after heart transplantation - Long-term follow-up after three decades of experience.

Dellgren G, Westerlind A, Liden H, Gäbel J, Bartfay SE, Bollano E, Holmberg E, Andersson B, Schersten H, Karason K.

Int J Cardiol. 2017 Mar 15;231:188-194. doi: 10.1016/j.ijcard.2016.12.186. Epub 2017 Jan 4.

PMID:
28087175
4.

Long-Term Follow-Up of Cardiac Rhythm in 320 Patients After the Cox-Maze III Procedure for Atrial Fibrillation.

Albåge A, Johansson B, Kennebäck G, Källner G, Scherstén H, Jidéus L; Swedish Arrhythmia Surgery Group.

Ann Thorac Surg. 2016 Apr;101(4):1443-9. doi: 10.1016/j.athoracsur.2015.09.066. Epub 2015 Dec 2.

PMID:
26654727
5.

Triclosan-coated sutures and sternal wound infections: a prospective randomized clinical trial.

Steingrimsson S, Thimour-Bergström L, Roman-Emanuel C, Scherstén H, Friberg Ö, Gudbjartsson T, Jeppsson A.

Eur J Clin Microbiol Infect Dis. 2015 Dec;34(12):2331-8. doi: 10.1007/s10096-015-2485-8. Epub 2015 Oct 2.

PMID:
26432552
6.

A structured blood conservation programme reduces transfusions and costs in cardiac surgery.

Ternström L, Hyllner M, Backlund E, Schersten H, Jeppsson A.

Interact Cardiovasc Thorac Surg. 2014 Nov;19(5):788-94. doi: 10.1093/icvts/ivu266. Epub 2014 Aug 14.

PMID:
25125140
7.

The Berglin apical stitch: a simple technique to straighten things out in atrial fibrillation surgery.

Albåge A, Jidéus L, Lidén H, Scherstén H; Swedish Arrhythmia Surgery Group.

Interact Cardiovasc Thorac Surg. 2014 Oct;19(4):685-6. doi: 10.1093/icvts/ivu220. Epub 2014 Jul 4.

PMID:
24997186
8.

Low mortality and low rate of perceived and documented arrhythmias after Cox maze III surgery for atrial fibrillation.

Johansson BI, Väärt O, Edvardsson N, Nyström B, Scherstén H, Karlsson T, Berglin E.

Pacing Clin Electrophysiol. 2014 Feb;37(2):147-56. doi: 10.1111/pace.12286. Epub 2013 Nov 15.

PMID:
24236990
9.

Pressure reflection in the pulmonary circulation in patients with severe mitral regurgitation indicates adverse postoperative outcome.

Bech-Hanssen O, Malm CJ, Nguyen L, Jeppsson A, Scherstén H, Ricksten SE.

Eur J Cardiothorac Surg. 2013 Dec;44(6):1037-44. doi: 10.1093/ejcts/ezt153. Epub 2013 Mar 21.

PMID:
23520236
10.

Triclosan-coated sutures reduce surgical site infection after open vein harvesting in coronary artery bypass grafting patients: a randomized controlled trial.

Thimour-Bergström L, Roman-Emanuel C, Scherstén H, Friberg Ö, Gudbjartsson T, Jeppsson A.

Eur J Cardiothorac Surg. 2013 Nov;44(5):931-8. doi: 10.1093/ejcts/ezt063. Epub 2013 Feb 22.

11.

A Swedish consensus on the surgical treatment of concomitant atrial fibrillation.

Swedish Arrhythmia Surgery Group, Ahlsson A, Jidéus L, Albåge A, Källner G, Holmgren A, Boano G, Hermansson U, Kimblad PO, Scherstén H, Sjögren J, Ståhle E, Aberg B, Berglin E.

Scand Cardiovasc J. 2012 Aug;46(4):212-8. doi: 10.3109/14017431.2012.671489. Epub 2012 Mar 27. Review.

PMID:
22375888
12.

[ECMO can be a bridge to lung transplantation. New method saves life in acute pulmonary failure according to a retrospective study].

Dellgren G, Schersten H, Kjellman U, Gilljam M, Swärd K, Thylén A, Silverborn M, Riise GC.

Lakartidningen. 2011 Aug 10-23;108(32-33):1493-7. Swedish. No abstract available.

PMID:
21922941
13.

Cardiac function in relation to rhythm outcome after intraoperative epicardial left atrial cryoablation.

Johansson B, Houltz B, Edvardsson N, Scherstén H, Karlsson T, Wandt B, Berglin E.

Scand Cardiovasc J. 2011 Dec;45(6):327-35. doi: 10.3109/14017431.2011.592855. Epub 2011 Aug 5.

14.

Usefulness of extracorporeal membrane oxygenation as a bridge to lung transplantation: a descriptive study.

Hämmäinen P, Schersten H, Lemström K, Riise GC, Kukkonen S, Swärd K, Sipponen J, Silverborn M, Dellgren G.

J Heart Lung Transplant. 2011 Jan;30(1):103-7. doi: 10.1016/j.healun.2010.08.017. Epub 2010 Oct 8.

PMID:
20934887
15.

One single dose of histidine-tryptophan-ketoglutarate solution gives equally good myocardial protection in elective mitral valve surgery as repetitive cold blood cardioplegia: a prospective randomized study.

Braathen B, Jeppsson A, Scherstén H, Hagen OM, Vengen Ø, Rexius H, Lepore V, Tønnessen T.

J Thorac Cardiovasc Surg. 2011 Apr;141(4):995-1001. doi: 10.1016/j.jtcvs.2010.07.011. Epub 2010 Aug 30.

16.

Lung transplantation in patients with cystic fibrosis and Mycobacterium abscessus infection.

Gilljam M, Scherstén H, Silverborn M, Jönsson B, Ericsson Hollsing A.

J Cyst Fibros. 2010 Jul;9(4):272-6. doi: 10.1016/j.jcf.2010.03.008. Epub 2010 Apr 18.

17.

The prevalence of moderate mitral regurgitation in patients undergoing CABG.

Wierup P, Nielsen SL, Egeblad H, Scherstén H, Kimblad PO, Bech-Hansen O, Roijer A, Nilsson F, Nielsen PH, Poulsen SH, Mølgaard H.

Scand Cardiovasc J. 2009 Feb;43(1):46-9. doi: 10.1080/14017430802430943.

PMID:
18932048
18.

Moderate mitral regurgitation in patients undergoing CABG--the MoMIC trial.

Wierup P, Egeblad H, Nielsen SL, Scherstén H, Kimblad PO, Bech-Hansen O, Roijer A, Nilsson F, McCarthy PM, Bouchard D, Jacobsen J, Johnsen SP, Poulsen SH, Mølgaard H; MoMIC Trial Investigators.

Scand Cardiovasc J. 2009 Feb;43(1):50-6. doi: 10.1080/14017430802430950.

PMID:
18850485
19.

Prolonged extracorporeal membrane oxygenation and circulatory support as bridge to lung transplant.

Broomé M, Palmér K, Scherstén H, Frenckner B, Nilsson F.

Ann Thorac Surg. 2008 Oct;86(4):1357-60. doi: 10.1016/j.athoracsur.2008.03.053.

PMID:
18805197
20.
21.

Expanding the donor pool: lung transplantation with donors 55 years and older.

Dahlman S, Jeppsson A, Scherstén H, Nilsson F.

Transplant Proc. 2006 Oct;38(8):2691-3.

PMID:
17098041
22.

Ex vivo evaluation of nonacceptable donor lungs.

Wierup P, Haraldsson A, Nilsson F, Pierre L, Scherstén H, Silverborn M, Sjöberg T, Westfeldt U, Steen S.

Ann Thorac Surg. 2006 Feb;81(2):460-6.

PMID:
16427831
23.

Effect of lung volume reduction surgery for emphysema on diaphragm function.

Hamnegård CH, Polkey MI, Thylen A, Nilsson F, Schersten H, Bake B.

Respir Physiol Neurobiol. 2006 Feb 28;150(2-3):182-90. Epub 2005 Jul 11.

PMID:
16009600
24.

Effects of lung volume reduction surgery on left ventricular diastolic filling and dimensions in patients with severe emphysema.

Jörgensen K, Houltz E, Westfelt U, Nilsson F, Scherstén H, Ricksten SE.

Chest. 2003 Nov;124(5):1863-70.

PMID:
14605061
25.

Mortality after mitral regurgitation surgery: importance of clinical and echocardiographic variables.

Bech-Hanssen O, Rydén T, Scherstén H, Odén A, Nilsson F, Jeppsson A.

Eur J Cardiothorac Surg. 2003 Nov;24(5):723-30.

PMID:
14583305
26.

Impaired vasodilation during endothelin-A receptor blockade in lung transplanted patients.

Silverborn M, Ambring A, Scherstén H, Friberg P, Jeppsson A, Nilsson F.

J Heart Lung Transplant. 2001 Feb;20(2):226. No abstract available.

PMID:
11250427
27.

Persistent high BAL fluid granulocyte activation marker levels as early indicators of bronchiolitis obliterans after lung transplant.

Riise GC, Andersson BA, Kjellström C, Martensson G, Nilsson FN, Ryd W, Scherstén H.

Eur Respir J. 1999 Nov;14(5):1123-30.

28.

Compromised antioxidant status and persistent oxidative stress in lung transplant recipients.

Williams A, Riise GC, Anderson BA, Kjellström C, Scherstén H, Kelly FJ.

Free Radic Res. 1999 May;30(5):383-93.

PMID:
10342331
30.
31.

Treatment with an antioxidant inhibits vascular changes caused by circulating lymphocytes during acute lung rejection in dogs.

Wiklund L, Nilsson F, Scherstén H, Sjöquist PO, Tazelaar H, Miller VM, McGregor CG.

Transplantation. 1997 Sep 27;64(6):807-11.

PMID:
9326402
32.

Inflammatory cells and activation markers in BAL during acute rejection and infection in lung transplant recipients: a prospective, longitudinal study.

Riise GC, Kjellström C, Ryd W, Scherstén H, Nilsson F, Mårtensson G, Andersson BA.

Eur Respir J. 1997 Aug;10(8):1742-6.

34.

Impaired endothelium-mediated vasodilatation in the peripheral vasculature of patients with acute pulmonary allograft rejection.

Scherstén H, Kirnö K, Ekroth R, Lundin S, Pettersson A, Kjellström C, Miller VM, Nilsson F.

J Heart Lung Transplant. 1996 Jun;15(6):556-63.

PMID:
8803752
35.

Systemic vascular effects during acute rejection of lung allografts.

Scherstén H, Tazelaar HD, Cale AR, Miller VM, McGregor CG.

Am J Physiol. 1996 Jun;270(6 Pt 2):H2191-6.

PMID:
8764273
36.

Effects of acute rejection and antirejection therapy on arteries and veins from canine single lung allografts.

Aarnio P, Scherstén H, Tazelaar HD, Miller VM, McGregor CG.

J Thorac Cardiovasc Surg. 1996 Jun;111(6):1219-29.

37.

Increased levels of endothelin-1 in bronchoalveolar lavage fluid of patients with lung allografts.

Scherstén H, Hedner T, McGregor CG, Miller VM, Mårtensson G, Riise GC, Nilsson FN.

J Thorac Cardiovasc Surg. 1996 Jan;111(1):253-8.

38.

Endothelin-1 in bronchoalveolar lavage during rejection of allotransplanted lungs.

Scherstén H, Aarnio P, Burnett JC Jr, McGregor CG, Miller VM.

Transplantation. 1994 Jan;57(1):159-61. No abstract available.

PMID:
8291104

Supplemental Content

Loading ...
Support Center